{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:48:37Z","timestamp":1757706517029},"reference-count":64,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Biotechnology (DBT), New Delhi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.129","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:25:39Z","timestamp":1318872339000},"page":"9352-9360","source":"Crossref","is-referenced-by-count":18,"title":["Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"SriJayaprakash Babu","family":"Uppada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajaz Ahmed","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rao Nageswara","family":"Donthamshetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.09.129_bib0005","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0010","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2006.01.031","article-title":"Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery","volume":"24","author":"Tripathi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0015","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1128\/IAI.00034-08","article-title":"Oral vaccination against bubonic plague using a live avirulent yersinia pseudotuberculosis strain","volume":"76","author":"Blisnick","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0020","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.vaccine.2009.01.050","article-title":"A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague","volume":"26","author":"Chichester","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-3988(10)60073-6","article-title":"Different strategies for preparation of non-tagged rV270 protein and its efficacy against Yersinia pestis challenge","volume":"23","author":"Wang","year":"2010","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1997.56.471","article-title":"Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis","volume":"56","author":"Anderson","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0040","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.vaccine.2007.01.017","article-title":"A plant-produced plague vaccine candidate confers protection to monkeys","volume":"25","author":"Mett","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"Smiley","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0050","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/mpat.2002.0498","article-title":"Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis","volume":"32","author":"Weeks","year":"2002","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0060","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.73.3.1532-1542.2005","article-title":"Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis","volume":"73","author":"Philipovskiy","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0065","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"Chiuchiolo","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0070","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0075","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1016\/j.vaccine.2008.08.007","article-title":"Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine","volume":"16","author":"Airhart","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0080","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1016\/j.vaccine.2009.07.015","article-title":"Protection against anthrax and plague by a combined vaccine in mice and rabbits","volume":"27","author":"Ren","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0090","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.vaccine.2009.10.143","article-title":"Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice","volume":"28","author":"Little","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.09.129_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015242","article-title":"Hijacking of the pleiotropic cytokine interferon-\u03b3 by the type III secretion system of Yersinia pestis","volume":"5","author":"Gendrin","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-3083.2010.02456.x","article-title":"Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta","volume":"72","author":"Qiu","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0105","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1016\/j.vaccine.2010.06.070","article-title":"Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA","volume":"28","author":"Torres-Escobar","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.09.129_bib0110","doi-asserted-by":"crossref","first-page":"e13047","DOI":"10.1371\/journal.pone.0013047","article-title":"Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model","volume":"5","author":"Xiao","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0115","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.vaccine.2010.06.054","article-title":"Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice","volume":"28","author":"Brewoo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0120","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.vaccine.2011.01.099","article-title":"A live attenuated strain of Yersinia pestis KIM as a vaccine against plague","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"issue":"January","key":"10.1016\/j.vaccine.2011.09.129_bib0125","article-title":"Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4049\/jimmunol.1003303","article-title":"IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection","volume":"186","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1574-695X.2000.tb01426.x","article-title":"Identification of immunodominant epitope of F1 antigen of Yersinia pestis","volume":"27","author":"Sabhnani","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2007.11.028","article-title":"T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-3083.2009.02365.x","article-title":"Cell-mediated immune response and Th1\/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis","volume":"71","author":"Gupta","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/72206","article-title":"IgG surfaces as an important component in mucosal protection","volume":"6","author":"Robert-Guroff","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0155","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/299592a0","article-title":"Tapping the immunological repertoire to produce antibodies of predetermined specificity","volume":"299","author":"Lerner","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.3008333","article-title":"Protection of cattle against foot-and-mouth disease by a synthetic peptide","volume":"232","author":"DiMarchi","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00430-009-0124-7","article-title":"Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles","volume":"198","author":"Uppada","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0170","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4049\/jimmunol.153.4.1895","article-title":"The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides","volume":"153","author":"Vogel","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0175","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/eji.1830200733","article-title":"A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes","volume":"20","author":"Del Giudice","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0180","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.4049\/jimmunol.149.10.3416","article-title":"Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB\/c mice to human immunodeficiency virus envelope glycoprotein","volume":"149","author":"Martinon","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0185","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0264-410X(94)00087-4","article-title":"Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides","volume":"14","author":"Sauzet","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0190","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.051623598","article-title":"Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice","volume":"98","author":"Kudryashov","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0195","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/eji.1830270528","article-title":"Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees","volume":"27","author":"BenMohamed","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/mi.2008.81","article-title":"A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge","volume":"2","author":"Zhang","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/IAI.35.2.417-424.1982","article-title":"Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity","volume":"35","author":"Chedid","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/153.3.628","article-title":"Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine","volume":"153","author":"Telzak","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0215","first-page":"1","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Kiyoshi","year":"2005","journal-title":"Inter Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.129_bib0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Shive Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/vir.0.80575-0","article-title":"Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg","volume":"86","author":"He","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-409X(01)00166-1","article-title":"Intranasal vaccination against plague, tetanus and diphtheria","volume":"51","author":"Alpar","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0235","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0264-410X(98)00089-9","article-title":"Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0240","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.vaccine.2008.12.004","article-title":"New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model","volume":"27","author":"Florindo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0245","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/IAI.00699-08","article-title":"Immunization with recombinant V10 protects Cynomolgus macaques from lethal pneumonic plague","volume":"76","author":"Cornelius","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jim.2006.10.015","article-title":"Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2","volume":"318","author":"Pau","year":"2007","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0255","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"VanCott","year":"1998","journal-title":"J Immun"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0260","first-page":"301","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague structure","volume":"12","author":"Derewenda","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0265","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.153.7.3148","article-title":"Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes","volume":"153","author":"Wrightsman","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0270","doi-asserted-by":"crossref","first-page":"9456","DOI":"10.1073\/pnas.91.20.9456","article-title":"Definition of a human suppressor T-cell epitope","volume":"91","author":"Mutis","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0285","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.1073\/pnas.86.23.9084","article-title":"Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes","volume":"86","author":"Tam","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0290","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/eji.1830210941","article-title":"Lack of H-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide","volume":"21","author":"Pessi","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0295","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0264-410X(97)00238-7","article-title":"Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein","volume":"16","author":"Nardin","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.171.1.299","article-title":"Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria","volume":"171","author":"Tam","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0305","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrd914","article-title":"Toll-like receptors as potential therapeutic targets for multiple diseases","volume":"1","author":"Zuany-Amorim","year":"2002","journal-title":"Nat Rev Drug Dis"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0310","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1038\/sj.emboj.7600867","article-title":"TLR agonists regulate PDGF-B production and cell proliferation through TGF-\u03b2\/type I IFN crosstalk","volume":"24","author":"Chow","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0315","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2010.05.006","article-title":"Enhanced T cell-independent antibody responses in c-Jun N-terminal kinase 2 (JNK2)-deficient B cells following stimulation with CpG-1826 and anti-IgM","volume":"132","author":"Cao","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2010-06-289009","article-title":"Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9","volume":"117","author":"Allacher","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2011.09.129_bib0330","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge lung mucosal Th17-Mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11015866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T14:17:54Z","timestamp":1686406674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11015866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":64,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11015866"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.129","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}